Pharmaceutical Law & Industry Report® Index-Summary

DACOGEN

– Myelodysplastic disease drug regimen, 370

DARVOCET

– Pain drug and heart attack (E.D. La.), 1624

DAXAS

– COPD, FDA panel vote, 500; FDA questions, 1194

DELAWARE

– Controlled substances monitoring program, 994

DEPAKOTE

– Marketing probe, e-mails sought (W.D. Va.), 518

DERMA-SMOOTHE

– Topical oil misleading website, 1593

DETROL

– Overactive bladder drug, nonobviousness (D.N.J.), 156; patent upheld (D.N.J.), 230

DIASTAT

– Anticonvulsant ANDA, 1095

DIET DRUGS

DIGITEK

– Economic suffering, class action (S.D. W.Va.), 158; no certification, 816
– Heart drug blamed for death (S.D. Ga.), 1221

DIOVAN

– Blood pressure drug, patent extension denial in Brazil, 26

DISCOUNTS

– Children's hospitals

See LEGISLATION, FEDERAL, HR 4994

– Conn. review of Rite Aid, 1114
– Fla. discount card available, 465
– Medicare

– 340B expanded enrollment, 1027

DISTRICT OF COLUMBIA

– PBM law preempted (D.C. Cir.), 913

DURAGESIC

– Pain patch maker's communications to MDs (W.Va.), 1501
– Wrongful death claim (Tex. App.), 457